- Home
- VRDN vs GABC Comparison
VRDN vs GABC Comparison
Compare VRDN & GABC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- GABC
- Stock Information
- Founded
- VRDN 2006
- GABC 1910
- Country
- VRDN United States
- GABC United States
- Employees
- VRDN N/A
- GABC N/A
- Industry
- VRDN Medical Specialities
- GABC Major Banks
- Sector
- VRDN Health Care
- GABC Finance
- Exchange
- VRDN Nasdaq
- GABC Nasdaq
- Market Cap
- VRDN 1.5B
- GABC 1.3B
- IPO Year
- VRDN N/A
- GABC N/A
- Fundamental
- Price
- VRDN $18.13
- GABC $39.75
- Analyst Decision
- VRDN Buy
- GABC Buy
- Analyst Count
- VRDN 12
- GABC 4
- Target Price
- VRDN $36.44
- GABC $44.75
- AVG Volume (30 Days)
- VRDN 1.6M
- GABC 118.8K
- Earning Date
- VRDN 02-25-2025
- GABC 01-31-2025
- Dividend Yield
- VRDN N/A
- GABC 2.72%
- EPS Growth
- VRDN N/A
- GABC N/A
- EPS
- VRDN N/A
- GABC 2.77
- Revenue
- VRDN $302,000.00
- GABC $247,156,000.00
- Revenue This Year
- VRDN $2.55
- GABC N/A
- Revenue Next Year
- VRDN N/A
- GABC $35.37
- P/E Ratio
- VRDN N/A
- GABC $14.35
- Revenue Growth
- VRDN N/A
- GABC N/A
- 52 Week Low
- VRDN $11.40
- GABC $30.66
- 52 Week High
- VRDN $27.20
- GABC $47.08
- Technical
- Relative Strength Index (RSI)
- VRDN 44.39
- GABC 43.98
- Support Level
- VRDN $16.60
- GABC $39.08
- Resistance Level
- VRDN $21.58
- GABC $40.34
- Average True Range (ATR)
- VRDN 1.00
- GABC 1.00
- MACD
- VRDN -0.16
- GABC 0.17
- Stochastic Oscillator
- VRDN 30.72
- GABC 67.99
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.
About GABC German American Bancorp Inc.
German American Bancorp Inc is a bank holding company. The Company's lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.